Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]

How do cancer registries operate in the UK?

Dr Jem Rashbass - Public Health England, UK

How do cancer registries operate in the UK? ( Dr Jem Rashbass - Public Health England, UK )

Hope, hype, misinformation and clinical evidence

Prof Michael Brada - University of Liverpool, Liverpool, UK

Hope, hype, misinformation and clinical evidence ( Prof Michael Brada - University of Liverpool, Liverpool, UK )

Clinical trials investigating proton therapy for other indications

Prof Nancy Mendenhall - University of Florida, Gainesville, USA

Clinical trials investigating proton therapy for other indications ( Prof Nancy Mendenhall - University of Florida, Gainesville, USA )

Building a succesful proton therapy centre

Prof James Metz - University of Pennsylvania, Philadelphia, USA

Building a succesful proton therapy centre ( Prof James Metz - University of Pennsylvania, Philadelphia, USA )

Proton therapy for paediatric indications

Prof Roger Taylor - Swansea University Medical School, Swansea, UK

Proton therapy for paediatric indications ( Prof Roger Taylor - Swansea University Medical School, Swansea, UK )

A model-based selection approach to identify suitable indications for proton...

Prof Johannes Langendijk - University of Groningen, Groningen, Netherlands

A model-based selection approach to identify suitable indications for proton therapy ( Prof Johannes Langendijk - University of Groningen, Groningen, Netherlands )

IBCD 2016: Patient access and regulatory challenges

Dr Denis Lacombe - EORTC Director General

IBCD 2016: Patient access and regulatory challenges ( Dr Denis Lacombe - EORTC Director General )

Taking complex genomic analysis into practice

Dr Philip Beer - Sanger Institute, Hinxton, UK

Taking complex genomic analysis into practice ( Dr Philip Beer - Sanger Institute, Hinxton, UK )

Genomic characterisation and risk stratification of AML

Dr Moritz Gerstung - European Bioinformatics Institute, Hinxton, UK

Genomic characterisation and risk stratification of AML ( Dr Moritz Gerstung - European Bioinformatics Institute, Hinxton, UK )

Screening Patients for Efficient Clinical Trial Access (SPECTA)

Dr Vassilis Golfinopoulos - EORTC, Brussels, Belgium

Screening Patients for Efficient Clinical Trial Access (SPECTA) ( Dr Vassilis Golfinopoulos - EORTC, Brussels, Belgium )

IBCD 2016: Integrating assays into clinical trials

Dr Tracy Lively - National Cancer Institute, USA

IBCD 2016: Integrating assays into clinical trials ( Dr Tracy Lively - National Cancer Institute, USA )

Design and value of immunohistochemical assays

Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA

Design and value of immunohistochemical assays ( Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA )

More from ecancer